 | Up a level |
Lutete, Gaston Tona, Mombo-Ngoma, Ghyslain, Assi, Serge-Brice, Bigoga, Jude D, Koukouikila-Koussounda, Felix, Ntamabyaliro, Nsengi Y, Ntoumi, Francine, Agnandji, Selidji T, Groger, Mirjam, Shin, Jangsik et al (show 7 more authors)
(2021)
Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study.
PLOS MEDICINE, 18 (6).
e1003669-.
Chandiwana, Nomathemba, Kruger, Chelsea, Johnstone, Hilary, Chughlay, Mohamed Farouk, Ju, Chung, Kim, Byungsu, Dineka, Yengiwe, Arbe-Barnes, Sarah, Miller, Robert, Owen, Andrew 
ORCID: 0000-0002-9819-7651 et al (show 6 more authors)
(2022)
Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial.
EBIOMEDICINE, 86.
104322-.